D.C. Mun. Regs. tit. 29, § 5210
5210.1 Assertive Community Treatment (“ACT”) services shall include:
5210.2 Assertive Community Treatment shall:
(2) A maximum of three (3) contacts may be collateral contacts;
(3) A minimum of three (3) contacts must be made by qualified practitioners, outlined in Chapter 34 of Title 22-A DCMR. One (1) of those contacts must be made by an MD/APRN and be direct to the individual (e.g., not a collateral contact or team meeting);
(4) The only face to face ACT contacts that may be provided via telehealth are MD and APRN contacts;
(5) Up to two (2) contacts per day may count towards the eight (8) required contacts.
(c) Require prior authorization; and
(d) Be delivered in accordance with the requirements set forth in Chapter 34 of Title 22-A DCMR.
5210.3 While a consumer is enrolled in ACT:
(a) Counseling/Therapy, Rehabilitation Day Services, IDT, CBI Levels 1, 2, and 3, TF-CBT, FFT, Trauma Recovery and Empowerment Services, and TST shall not be billed, unless otherwise authorized;
(b) Medication/Somatic Treatment and Community Support shall not be billed unless:
(1) Rendered by a provider that is different from the ACT provider, in the first thirty (30) calendar days of the consumer's enrollment into ACT or within thirty (30) calendar days prior to disenrollment from ACT; or
(2) The service is otherwise authorized; and
(c) Crisis/Emergency Services shall not be billed, unless rendered by a provider that is different from the ACT provider, in the first thirty (30) calendar days of the consumer's enrollment into ACT or within thirty (30) calendar days prior to disenrollment from ACT.
5210.4 An ACT provider shall not bill Screening, Assessment, and Diagnosis services, unless the result of the ACT provider's assessment is a determination that ACT services are not indicated for the consumer.
SOURCE: Final Rulemaking published at 49 DCR 4860 (May 24, 2002); as amended by Final Rulemaking published at 69 DCR 012836 (October 21, 2022); as amended by Final Rulemaking published at 71 DCR 002888 (March 15, 2024).